This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.
Dr. Raouf Ben Abdelali, head of the Hematology and Oncology division at Cerba Laboratory, will share how his team implemented an automated protocol for Agilent's SureSelect XT HS and SureSelect XT Low Input target enrichment technology. Dr. Abdelali will review results from a wide variety of sample types (blood, fresh frozen tissue, and FFPE), sample quality, and DNA input amounts (10-200 ng).
Dr. Abdelali will discuss the design and workflow optimization of custom NGS panels for oncogenetics and onco-hematology. He will share his team's research with somatic exomes and parallel RNA-seq analysis.
Cerba provides private and hospital laboratories in more than 50 countries with a wide range of specialized clinical pathology tests in the field of hereditary genetic diseases and cancer genomics.